Accenture (NYSE: ACN) is to acquire OpusLine, a Paris, France-based consulting company that provides strategic advisory and transformational services to public- and private-sector healthcare providers as well as life sciences and insurance companies in the country.
The amount of the deal, which requires prior consultation with the relevant works councils and would be subject to customary closing conditions, was not disclosed.
Following this acquisition, Accenture will provide health industry clients with the latest innovations in areas such as data analytics and artificial intelligence (AI) and support the health ecosystem with highly differentiated services.
Founded in 2012 by Alix Pradere, OpusLine is a large independent health consulting company, employing more than 85 consultants.
Following the acquisition, OpusLine’s employees would join the newly created Health practice of Accenture Strategy & Consulting and enhance its ability to help clients innovate and deliver digital innovation across their organizations.
This transaction follows other healthcare- and life sciences-related acquisitions by Accenture in recent years, including the 2019 acquisitions of Clarity Insights, Knowledgent and Enterprise System Partners, and the 2017 acquisition of LabAnswer.